Neonatal Abstinence Syndrome

"Neonatal Abstinence Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.

Descriptor ID	D009357
MeSH Number(s)	C16.614.610 C25.775.650 F03.900.650
Concept/Terms	Neonatal Abstinence Syndrome Neonatal Abstinence Syndrome Substance Withdrawal, Neonatal Neonatal Withdrawal Syndrome Neonatal Withdrawal Syndromes Syndrome, Neonatal Withdrawal Syndromes, Neonatal Withdrawal Withdrawal Syndrome, Neonatal Withdrawal Syndromes, Neonatal Abstinence Syndrome, Neonatal Abstinence Syndromes, Neonatal Neonatal Abstinence Syndromes Syndrome, Neonatal Abstinence Syndromes, Neonatal Abstinence Neonatal Substance Withdrawal Neonatal Substance Withdrawals Substance Withdrawals, Neonatal Withdrawal, Neonatal Substance Passive Addiction, Neonatal Passive Addiction, Neonatal Addiction, Neonatal Passive Addictions, Neonatal Passive Neonatal Passive Addiction Neonatal Passive Addictions Passive Addictions, Neonatal

Below are MeSH descriptors whose meaning is more general than "Neonatal Abstinence Syndrome".

Diseases [C]
Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Infant, Newborn, Diseases [C16.614]
Neonatal Abstinence Syndrome [C16.614.610]
Chemically-Induced Disorders [C25]
Substance-Related Disorders [C25.775]
Neonatal Abstinence Syndrome [C25.775.650]
Psychiatry and Psychology [F]
Mental Disorders [F03]
Substance-Related Disorders [F03.900]
Neonatal Abstinence Syndrome [F03.900.650]

Below are MeSH descriptors whose meaning is related to "Neonatal Abstinence Syndrome".

Below are MeSH descriptors whose meaning is more specific than "Neonatal Abstinence Syndrome".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neonatal Abstinence Syndrome" by people in this website by year, and whether "Neonatal Abstinence Syndrome" was a major or minor topic of these publications.

Bar chart showing 10 publications over 6 distinct years, with a maximum of 3 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	0	1	1
2016	1	0	1
2017	1	0	1
2018	2	0	2
2019	2	1	3
2020	2	0	2

Below are the most recent publications written about "Neonatal Abstinence Syndrome" by people in Profiles.

Young LW, Hu Z, Annett RD, Das A, Fuller JF, Higgins RD, Lester BM, Merhar SL, Simon AE, Ounpraseuth S, Smith PB, Crawford MM, Atz AM, Cottrell LE, Czynski AJ, Newman S, Paul DA, Sánchez PJ, Semmens EO, Smith MC, Turley CB, Whalen BL, Poindexter BB, Snowden JN, Devlin LA. Site-Level Variation in the Characteristics and Care of Infants With Neonatal Opioid Withdrawal. Pediatrics. 2021 01; 147(1).

View in: PubMed
Adrian A, Newman S, Mueller M, Phillips S. A Mixed-Methods Study to Investigate Barriers and Enablers to Nurses' Implementation of Nonpharmacological Interventions for Infants With Neonatal Abstinence Syndrome. Adv Neonatal Care. 2020 Dec; 20(6):450-463.

View in: PubMed
Hudson J, Charron E, Bedi J, Dickes L, Mayo R, Sherrill WW. Managing Abstinence in Newborns (MAiN): Redesigning NAS care for the mother/baby unit. Healthc (Amst). 2020 Mar; 8(1):100404.

View in: PubMed
Conradt E, Flannery T, Aschner JL, Annett RD, Croen LA, Duarte CS, Friedman AM, Guille C, Hedderson MM, Hofheimer JA, Jones MR, Ladd-Acosta C, McGrath M, Moreland A, Neiderhiser JM, Nguyen RHN, Posner J, Ross JL, Savitz DA, Ondersma SJ, Lester BM. Prenatal Opioid Exposure: Neurodevelopmental Consequences and Future Research Priorities. Pediatrics. 2019 09; 144(3).

View in: PubMed
Ecker J, Abuhamad A, Hill W, Bailit J, Bateman BT, Berghella V, Blake-Lamb T, Guille C, Landau R, Minkoff H, Prabhu M, Rosenthal E, Terplan M, Wright TE, Yonkers KA. Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine. Am J Obstet Gynecol. 2019 07; 221(1):B5-B28.

View in: PubMed
Boyars L, Guille C. Treatment of Perinatal Opioid Use Disorder. Obstet Gynecol Clin North Am. 2018 Sep; 45(3):511-524.

View in: PubMed
Summey J, Chen L, Mayo R, Charron E, Hudson JA, Sherrill WW, Dickes L. Early Treatment Innovation for Opioid-Dependent Newborns: A Retrospective Comparison of Outcomes, Utilization, Quality, and Safety, 2006-2014. Jt Comm J Qual Patient Saf. 2018 06; 44(6):312-320.

View in: PubMed
Dickes L, Summey J, Mayo R, Hudson J, Sherrill WW, Chen L. Potential for Medicaid Savings: A State and National Comparison of an Innovative Neonatal Abstinence Syndrome Treatment Model. Popul Health Manag. 2017 12; 20(6):458-464.

View in: PubMed
Hudson J, Mayo R, Dickes L, Chen L, Sherrill WW, Summey J, Dalton B, Dankovich K. Early Treatment for Neonatal Abstinence Syndrome: A Palliative Approach. Am J Perinatol. 2017 05; 34(6):576-584.

View in: PubMed
Wagner CL, Katikaneni LD, Cox TH, Ryan RM. The impact of prenatal drug exposure on the neonate. Obstet Gynecol Clin North Am. 1998 Mar; 25(1):169-94.

View in: PubMed

People

Explore

Similar Concepts

Top Journals